Community 365 Roundtable on Time to Treatment

On Tuesday 2 July from 16:00-18:30 CEST, the 2024 ECO Community 365 Roundtable series will continue with a spotlight placed on the issue of ‘Time to Treatment’. The discussion will investigate the level to which patients are experiencing unnecessary and concerning levels of delay across the cancer care continuum – from a cancer being detected, to diagnosed, to treated. This includes examining delays across different European regions and tumour types, identifying factors contributing to the delays, and exploring potential solutions.

 

The Roundtable will be co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ); and Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe. The event will hear from oncology professionals, patient representatives, technologists, researchers, and health system managers.

02 July 2024 16:00 - 18:30 CEST

Virtual

Apply for Registration

TTT Roundtable web

Evaluating the time between cancer diagnosis and treatment is crucial as timely intervention improves survival rates, reduces patient anxiety and enhances treatment efficacy and efficiency. Participants to the roundtable will explore ways to ensure equitable access to care, improve cancer policy on this topic, and accelerate access to innovations in cancer treatment. The conclusions of the discussions will be synthetised in a future Policy Action Report.

Programme

The Roundtable will be co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ); and Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe.

16:00 – 16:10 Welcome and introductions 

Prof Peter Albers and Aleksandra Kaczmarek will introduce the concepts and themes of the roundtable. The introduction will also include a presentation from Zoë Parker, Policy Research and EU Projects Assistant, ECO European Cancer Pulse team.

16:10 – 16:55  The role of digitisation in reducing waiting times 

Co-Chaired by Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe and Jose Luis Gomez Ruiz, Vice President, Public Policy and Advocacy Europe, Middle East and Africa, BD

  • Jesus Garcia-Foncilla, President, ECO Foundation; Presentation of OncoOptimal project results
  • Grant Carroll, Chief Pharmacist, National Cancer Information System (NCIS)

Speakers and panellists will present and comment upon the role of digitisation in reducing waiting times from a variety of perspectives. Prof. Jesus Garcia-Foncilla, President, ECO Foundation will present the experience of the OncoOptimal project as a case study.

16:55 – 17:40 Means and methods to better coordinate the patient pathway

Co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)

  • Dr Corinne Balleyguier, Head of Nuclear Medicine Unit (interim), Gustave Roussy
  • Martina Fontana, Policy & Research Officer, Europa Donna

Speakers and panellists will present and comment upon the role of digitisation in reducing waiting times from a variety of perspectives. Prof. Jesus Garcia-Foncilla, President, ECO Foundation will present the experience of the OncoOptimal project as a case study.

17:40 – 18:25 Tackling delay in new treatment access 

To be co-chaired by Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe and James Laubner, Director International Government Affairs - Europe, Canada, Mid-East, Africa and Latin America, Amgen

  • Mihai Rotaru, Director Market Access, EFPIA; Presentation of the main results of the EFPIA Patient WAIT Indicator
  • Marie Phillips, Research Assistant, Center for the Evaluation of Value and Risk in Health, Tufts University School of Medicine
  • Alfonso Aguarón, Policy Officer, Lung Cancer Europe
  • Rebecca Steele, Secretariat, European Alliance for Value in Health

Speakers and panellists will present and comment the role of early access schemes in providing patients with access to new treatments in accelerated time pathways. Mihai Rotaru, Director Market Access, at EFPIA will present the main results of the Patients W.A.I.T Indicator Survey series. Marie Phillips, from Tufts University School of Medicine will present recent research on multi-stakeholder perspectives on managing accelerated patient access to potentially beneficial medicines.

18:25 – 18:30 Event conclusion and next steps 

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Aleksandra Kaczmarek Public Policy Manager, Digestive Cancers Europe
  • Jesus Garcia-Foncillas President, Fundación ECO
  • Martina Fontana Policy and Research Officer, Europa Donna
  • Mihai Rotaru Director Market Access EFPIA
  • Marie Phillips Research Assistant, Tufts Medical Center

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Aleksandra Kaczmarek Public Policy Manager, Digestive Cancers Europe
  • Jesus Garcia-Foncillas President, Fundación ECO
  • Martina Fontana Policy and Research Officer, Europa Donna
  • Mihai Rotaru Director Market Access EFPIA
  • Marie Phillips Research Assistant, Tufts Medical Center
  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ) Read Bio
  • Aleksandra Kaczmarek Public Policy Manager, Digestive Cancers Europe Read Bio
  • Jesus Garcia-Foncillas President, Fundación ECO Read Bio
  • Martina Fontana Policy and Research Officer, Europa Donna Read Bio
  • Mihai Rotaru Director Market Access EFPIA Read Bio
  • Marie Phillips Research Assistant, Tufts Medical Center Read Bio
  • Jose Luis Gomez Ruiz Vice President, Public Policy and Advocacy Europe, Middle East and Africa, BD Read Bio
  • Alfonso Aguarón Policy Officer, Lung Cancer Europe
  • Rebecca Steele Secretariat, European Alliance for Value in Health Read Bio
  • Grant Carroll Chief Pharmacist, National Cancer Information System (NCIS) Read Bio
  • James Laubner Director International Government Affairs - Europe, Canada, Mid-East, Africa and Latin America, Amgen Read Bio
  • Zoë Parker POLICY RESEARCH AND EU PROJECTS ASSISTANT, European Cancer Organization

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Aleksandra Kaczmarek Public Policy Manager, Digestive Cancers Europe
  • Jesus Garcia-Foncillas President, Fundación ECO
  • Martina Fontana Policy and Research Officer, Europa Donna
  • Mihai Rotaru Director Market Access EFPIA
  • Marie Phillips Research Assistant, Tufts Medical Center

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Aleksandra Kaczmarek Public Policy Manager, Digestive Cancers Europe
  • Jesus Garcia-Foncillas President, Fundación ECO
  • Martina Fontana Policy and Research Officer, Europa Donna
  • Mihai Rotaru Director Market Access EFPIA
  • Marie Phillips Research Assistant, Tufts Medical Center